Abu Dhabi, April 2024: Abu Dhabi Stem Cells Center (ADSCC) has partnered with Emirates Red Crescent (ERC) to enhance accessibility to bone marrow transplants for patients in need, providing them with treatment and support via the centre’s dedicated Abu Dhabi Bone Marrow Transplant (ADBMT©) Program.
Under the partnership, ADSCC will provide medical consultations to patients referred by the medical committee of ERC. In addition, both entities will join efforts in fundraising initiatives aimed at supporting and financing BMT procedures for underprivileged patients.
The partnership aims to provide these critical treatments to individuals affected by various blood cancers, blood disorders, and autoimmune diseases like multiple sclerosis, ensuring they receive the highest standard of care and support throughout their treatment process by Abu Dhabi Bone Marrow Transplant program (ADBMT©) at ADSCC, which is accredited as a Center of Excellence in Hematopoietic Stem Cell Transplantation by the Department of Health Abu Dhabi.
His Excellency Mohammed Al Fahim, Deputy Secretary General of Support Services Sector at ERC, and Dr. Maysoon Al Karam, Chief Medical Officer of ADSCC, signed the agreement.
Also Read: Abu Dhabi Stem Cells Center (ADSCC) Achieves Milestone: UAE’s First CAR-T Cell Manufactured
His Excellency Mohammed Al Fahim said: “The agreement with Abu Dhabi Stem Cells Center embodies the vision of the UAE Red Crescent of enhancing humanitarian partnerships with various local sectors, particularly the healthcare sector, which is currently a priority in the authority’s local and international efforts. It reflects the shared goal between both parties of alleviating the suffering of patients, supporting their health needs, and strengthening cooperation to achieve better health outcomes for the Red Crescent’s beneficiaries.”
Dr Maysoon Al Karam said: “The UAE’s leadership has always placed the health and wellbeing of its people at the forefront of its priorities, ensuring that high-quality healthcare services are accessible to all. This commitment underscores the essence of our collaboration with the Emirates Red Crescent, reflecting our joint vision to expand the accessibility of advanced medical treatments. Through such collaborations, we aim to bridge the gap in healthcare access, ensuring that state-of-the-art treatments are accessible to those in need.’’
ADSCC has been leading advancements in cellular therapy, particularly in bone marrow transplantation. In 2020, ADSCC launched its Abu Dhabi Bone Marrow Transplant Program, the first comprehensive program in the UAE to provide autologous and allogeneic hematopoietic stem cells transplants (HSCT) for adult and pediatric patients. Since its inception, ADSCC has achieved noteworthy milestones in BMT.
